Stock Martket BSE » free share tips

Free Day Trading Tips – 06 Feb 2012

admin — Mon, 06 Feb 2012 03:37:09 +0000

Buy Shipping Corporation of India at Rs 67.1-68.8, Stop loss at Rs 66.4, Target at Rs 71.1-75.2

Buy Sintex Industries at Rs 92.1-95.5, Stop loss at Rs 89.5, Target at Rs 101.4-110.7

Buy Pantaloon Retail at Rs 175.10, Stop loss at Rs 172, Target at Rs 181

Buy BEML at Rs 548.20, Stop loss at Rs 544, Target at Rs 556

Free Trading Tips – 12 Jan 2012

admin — Thu, 12 Jan 2012 03:36:31 +0000

Buy ABB at Rs 628.8-635.4, Stop loss at Rs 624, Target at Rs 646.8-664.8 Buy SAIL (Steel Authority of India) at Rs 89.2-90.7, Stop loss at Rs 88.4, Target at Rs 93.1-96.9 Related posts:Free Intraday Tips – 5 Jan 2012 Free Day Trading Stock Tips – 09 March 2010 Free Day Trading Tips – 29 [...] Related posts:

Free Intraday Tips – 5 Jan 2012

admin — Thu, 05 Jan 2012 03:31:32 +0000

Buy Tata Motors at Rs 195-198.5, Stop loss at Rs 193.1, Target at Rs 203.9-212.8 Buy ONGC at Rs 262.5-265.1, Stop loss at Rs 261.6, Target at Rs 268.6-274.7 Related posts:Free Trading Tips – 12 Jan 2012 Free Day Trading Tips – 06 Feb 2012 Free Day Trading Tips – 29 March 2011 Related posts:

Free Day Trading Tips – 12 August 2011

admin — Fri, 12 Aug 2011 04:09:56 +0000

Buy RCF around Rs 81.30-84.30, stop loss Rs 79.40, book profit at Rs 89.10-96.90 Sell Crompton Greaves around Rs 148.20-145.90, stop loss Rs 149.30, cover short at Rs 142.50-136.70 Related posts:Free Intraday Stock Tips – 01 April 2010 Free Day Trading Tips – 29 March 2011 Free Intraday Stock Tips – 18 May 2010 Related posts:

Buy Glenmark Pharma

admin — Wed, 30 Mar 2011 02:26:38 +0000

Base business to grow over 18% CAGR:

We expect robust growth in base business (18% CAGR growth over FY10-13E) driven by growth in US generics (18.2% CAGR), Latam business (19.4% CAGR over FY10-13E) & domestic formulation business (18.4% CAGR over FY10-13E). The growth in US market can be attributed to growth in high margin derma products, hormonal products & others. Out of the 22 ANDAs filed for derma products, the company has approval of 18 ANDAs. Other opportunities in US market mainly include Oxycodone, Cutivate, & calcipotriene. Domestic market is expected to grow mainly on the back of new launches in key therapeutic segments viz respiratory, dermatology & anti-infectives. Completion of successful restructuring for Brazilian operations to add to the growth on Latam business.

EBITDA margins to improve by 160bps to 27.4% in FY12:

Company recently received an USFDA approval for Norethindrone & Ethinyl Estradiol tablets which marks company’s fourth entry into hormonal product portfolio & third in oral contraceptive segment. Company’s total pipeline for these products is worth ~ USD 141mn (IMS Health, Dec 2010). These products are very high margin products & presence of few players leads to higher profit realization.

Attractive First to File opportunity :

The company has a total of 11 Para IV (Mkt size – USD 6.8bn) of which the company has sole FTF (Mkt size – USD 1.6bn) opportunities on four products. Out of the four products, Malarone & Cutivate are expected to be launched in Q3FY12 & Q1FY12 respectively. This brings into account NPS/share of Rs 2 & 1.2 respectively for the company. Being FTF player it would be entitled to an exclusivity of 180 days.

R&D progress on track:

The company has total of 10 molecules in pipeline out of which two are in-licensed & one-out licensed. NCE viz Crofelemer (Mkt size – USD 80mn) & GRC15300 (USD 9bn) are progressing well and the launch is expected to happen in Q4FY12 & post FY15 respectively. This brings in NPV/share of Rs 25 & 22 respectively. Also recently the company’s NCE GRC-17536 got approval for human trials in Europe for multiple indications.

Free Day Trading Tips – 29 March 2011

admin — Tue, 29 Mar 2011 01:59:18 +0000

Buy SREI Infrastructure Finance at CMP Rs 43.95, Stop Loss: 42.25, Target 48

Buy Canara Bank at Rs 622.45, stop loss Rs 600, target Rs 660

Buy Chennai Petro at Rs 212.50 and on dips to Rs 208, stop loss Rs 200, target Rs 235

Buy Crompton Greaves at Rs 268.20 and Bank Of Baroda at Rs 927.90. Up side potential 4%.

Buy Mundra Port at Rs 137.95 and on dips to Rs 135, target Rs 145, stop loss Rs 132

Buy Kalpataru Power initially above Rs 123 and then on dips to Rs 118, target Rs 140, closing stop loss Rs 112

CSS Tech – Stocks To Watch

admin — Sun, 27 Mar 2011 11:38:55 +0000

CSS Technergy Ltd.

BSE 590050

NSE CSSTECH

CSS Tech is engaged in providing turnkey ITES solutions adopting ICR, OMR, OCR in various e-governance projects and in end-to-end student data management for arge-scale entrance examinations. CSS also does end-to-end meter-to-cash solutions and adoption of firmware upgrades in Spot Billing Machines which are still being used on a large scale due to their highROI and high efficiency. CSS serves more than 20 million consumers across india through its utility services division in 8 states.

CSS is serving customers like FedeX,Fujitsu, PSEB,Wipro, GE, CMC,Capgemini D E Shaw, MESCOM, Mahavitaran etc. CSS expertise summary :- E-governance project planning and implementation. End to End document management One of India’s largest Utility IT Services company offering services to several DISCOMs Serving 10 top utilities in the country CSS stores, manages and maintains close to 10 million customer data on the servers in a secure manner CSS is an empanelled member of PFC for bothMDASP and GSP for R-APDRP programs of Govt Empanelled with UIDAadhaar in the highest T2,F4 category for all-India capability. CSS has its own suite of customer- proven products for each of the vertical it operates in. These solutions are used on a regular basis at CS project locations and at client deployment areas. Its suite of products includes: EBAS, MetTecaa, DMSol, Loyaltrack.

So far, performance of CSS has been lacklustre. However, in view of certain developments, CSS has much better and brighter future prospects. As company is T2F4 level categhorized by UIDAI, it has bagged contract for 22 disctricts covering the states of Bihar, West Bengal, Andhra Pradesh and Orissa. Company can cover the whole of eligible numbers with in these 22 districts and additionally also bid for other locations with different registrars. From this new business, company is eligible to capture 50 million nos of UID Project. THIS PROJECT CAN LEAD TO 200 CRORE REVENUES TO CSS IN 3 YEARS. Company has already started implementation of this prestigious project which is being done through Own Assets as well as Outsourcing. For implementation of this project, company needs to spend approx 3 lac for each work-station and total capex will be 600 lacs for 200 workstations. To raise money for this project, CSS may make preferential offer of equity shares in near future (that is why, equity for next year has been shown as 7 crores. Above estimates have been arrived at only considering orders in hand. If CSS manages to capture more orders from UID, company’s performance can be spectacular in coming years. Its current market cap is just 14 crores which is really considering:

Book Value is Rs 35.50, Scrip is available at 3.80xFY12E Eps, Scrip is trading at 2.45xFY12E Eps, So far, share price has been lying low due to lacklustre performance. However, in near future, company’s performance will witness huge improvement and share price too can climb sharply. Scrip at Cmp appears risk-free. Floating stock is low. Investors may gain 50-70% in next 6 months.

Free Day Trading Tips – 28 March 2011

admin — Sun, 27 Mar 2011 11:28:53 +0000

Buy IFCI CMP 53.80 Target 58 Stop Loss 49.50

Buy JetAirways CMP – 441.35 Stoploss – 439 Target – 450

Buy TV TodayNetwork CMP – 62.10 Target – 65.50 Stoploss – 60.00

Buy Sterlite Ind CMP – 168.50 Target – 174 Stoploss – 158

Buy Ashok Leyland CMp – 56.55 Target – 60.00 Stoploss – 54

Buy United Phos CMP – 145.75 Target – 155 Stoploss – 140

Buy Mercator Lines CMP – 38.40 Target – 43 Stoploss – 35

Free Intraday Stock Tips – 18 May 2010

admin — Tue, 18 May 2010 03:02:42 +0000

Buy REC around Rs 267.30-272.10, stop loss Rs 265, book profit at Rs 279.20-291.10

Sell Prakash Industries around Rs 178.40-171.50, stop loss Rs 181, cover short at Rs 161.90-145.50

Sell Hindalco with stop loss of Rs 168 for a target of Rs 150

Sell Sterlite Industries with stop loss of Rs 716 for a target of Rs 660

Binani Industries – Analyst Corner

admin — Sun, 16 May 2010 03:02:51 +0000

Binani Industries (Rs. 117) (Code : 500059)

Target Price = Rs.182 ; Time Frame = 6months ;

Market Cap = 347 crores ; Shares O/S. = 2,95,96,425

Debt/Equity Ratio = 0.52 : 1 ; 52 week High/Low = 143/47

Face Value = Rs.10 ; B.V. = Rs. 68 ; P/E = 1.9 ; P/B: 1.7

The Braj Binani Group is a well-diversified industrial house with a 136-year history behind it. Today, the group is actively working in the core sectors of Cement, Zinc, Glass Fibre and Downstream Composite Products.

Binani Industries Ltd. is essentially a holding & investment company and currently holds strategic stake in listed entity Binani Cements and various unlisted entities like Binani Zinc, Goa Glass Fibre and BT Composites. While calculating NAV of BIL we have valued

Binani Cements at Market Value and all unlisted companies like Binani zinc, Goa Glass Fibre and BT Composites at historical price as they are still unlisted. Still at CMP of Rs.117, the stock is available at 68% discount to its NAV which seems to be quite attractive. Also at this price its dividend yield is 2.54%. At the current price of Rs.117, the stock is trading at 1.7x FY11E earnings. Return for investors in these companies can be two fold driven by appreciation of its investments and decrease in discount. Holding company generally trades at discount but here what we believe is that BIL is trading at a discount much higher than its historical average of 50%. We expect the discount to decrease and move towards its historical average of 50% as investors would flock towards buying these undervalued companies, keeping in mind sharp recovery in the stock market and improved sentiments. We recommend BUY with a price target of Rs.182 (50% of Current NAV per share) given the company’s holdings in subsidiaries and future growth potential.